Table 3.
Preferred routes of administration and mode of access to cannabis-based extracts if medicinal cannabis became legally available (N = 65).
| Preferred routes of administration | N (%) |
|---|---|
| Oral use - Liquid (e.g. oil) | 44 (67.7%) |
| Oral use - Tablets/capsules (swallowed) | 21 (32.3%) |
| I do not care as long as it is effective | 18 (27.7%) |
| Oral use - Chewable tablet | 11 (16.9%) |
| Mouth spray | 9 (13.8%) |
| Via the nose - intranasal spray | 6 (9.2%) |
| Via the nose - Inhalant (e.g. like “Vick’s vapor”) | 5 (7.7%) |
| Skin patches | 5 (7.7%) |
| Edible (e.g., butter/resin, tea infusion) | 2 (3.1%) |
| Smoked – Joint | 2 (3.1%) |
| Vaporiser | 2 (3.1%) |
| Suppository | 2 (3.1%) |
| Other: Raw cannabis material for juicing | 1 (1.5%) |
| Other: Slow-release tablet administered once daily | 1 (1.5%) |
| Smoked - Water pipe (“bong”) | — |
| Preferred mode of access | |
| From a pharmacy like other medication | 52 (80%) |
| From a special licensed cannabis dispensary | 16 (24.6%) |
| I do not care as long as there is regular supply | 9 (13.8%) |
| Grow or make your own | 7 (10.8%) |
| From a supplier | 5 (7.7%) |
| Trade/buy from a friend | 2 (3.1%) |
| No opinion | 1 (1.5%) |
| Other: Sold as a supplement | 1 (1.5%) |
Respondents were asked to choose their preferred routes of administration and access models from a list containing several possibilities therefore sum of responses do not add to 100%.